# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001401914-24-000027
Filing Date
2024-04-26
Accepted
2024-04-26 16:15:45
Documents
6
Period of Report
2024-06-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | a2024def14adefinitiveproxy.htm | DEF 14A | 579396
2 |  | darebioinlinefullcolorrgbaa.jpg | GRAPHIC | 130914
3 |  | darebioscienceinc_vxprxyxpb.jpg | GRAPHIC | 516721
4 |  | darebioscienceinc_vxprxyxpc.jpg | GRAPHIC | 241390
5 |  | image1a.jpg | GRAPHIC | 74670
6 |  | imagea.jpg | GRAPHIC | 103294
| Complete submission text file | 0001401914-24-000027.txt |  | 2039034

Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

EIN.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36395 | Film No.: 24883977
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)